Patent applications published 22 June 2011

Published: 6-Jul-2011

Selected patent applications from the weekly European Patents Bulletin


  • Topical formulations for treatment of neuropathy
    Taraxos 2334176*

  • Peptide toxin formulation
    Vestaron 2334177*

  • Compsns and methods for the treatment of bowel diseases with granulated mesalamine
    Dr Falk Pharma 2334178*

  • AHCY hydrolase inhibitors for treatment of hyper homocysteinemia
    Merck Sharp & Dohme 2334179*

  • Alleviating disorders with combining agents that increase epoxygenated fatty acids and agents that increase CAMP
    The Regents of the University of California 2334180*

  • Phthalimide derivative metabotropic glutamate ligands
    Merck Sharp & Dohme 2334181*

  • Method of treating organophosphorus poisoning
    University of Maryland; The Government of the United States as Represented by the Secretary of the Army 2334182*

  • Sulphonamide derivative metabotropic glutamate R4 ligands
    Merck Sharp & Dohme 2334183*

  • Fungicidal mixture, containing fenpropidin and penxonazole
    Syngenta Participations 2334184*

  • Compsns and methods of using (R)-pramipexole
    Knopp Neurosciences 2334185*

  • Compacted cinacalcet
    Ratiopharm 2334284*

  • Improvements in the absorption of thera-peutic agents across mucosal membranes or the skin
    Critical Pharmaceuticals 2334285*

  • Low pH retinoid topical compsns
    Amcol International 2334286*

  • Hot-melt extrusion of modified release multi-particulates
    Board of Regents, The University of Texas System 2334297*

  • Microencapsulation process with solvent and salt
    Surmodics Pharmaceuticals 2334288*

  • Controlled release nimesulide compsn
    Europharmaceuticals 2334289*

  • Drug delivery system for econazole, moxifloxacin, and rifampicin
    Lifecare Innovations 2334290*

  • Compsns for percutaneous administration
    Novartis 2334291*

  • Method of determining a phosphorus binder dosage for a dialysis patient
    Fresenius Medical Care Holdings 2334292*

  • Compsns comprising polyhydroxylate fatty alcohol derivatives and the therapeutic uses
    Meretzki, Shai 2334293*

  • Compsn for the treatment of alopecia
    ProxiPHARM 2334294*

  • Pharmaceutical compsn comprising eixosapentenoic acid and nicotinic acid and methods of using same
    Amarin Corp; Manku, Mehar 2334295*

  • Immunomodulating activities
    Novogen Research 2334296*

  • Lofexidine enantiomers for use as a treatment for CNS disease and pathologies and its chiral synthesis
    Agean 2334297*

  • Novel single unit carbapenem amidoglycoside formulations
    Chaudhary, Manu 2334298*

  • Pharmaceutical compsn comprising gaboxadol and an inhibitor of PATL or OAT
    H Lundbeck 2334299*

  • Compsn and method for treatment of preterm labour
    The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin 2334300*

  • Macrocyclics pyrimidines as aurora kinase inhibitors
    Merck Serono 2334301*

  • Dosage forms for weakly ionisable compounds
    Cima Labs 2334302*

  • Tyrosine kinase receptor TYR03 as a therapeutic target in the treatment of cancer
    Institut Curie; Centre National de la Recherche Scientifique; Universite Paris-Est Cretil val de Marne 2334303*

  • Therapeutic bone growth and regeneration
    Agency for Science, Technology & Research, Singapore 2334304*

  • Bioadhesive constructs
    KNC NER Acquisition Sub 2334305*

  • Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
    The General Hospital Corp 2334306*

  • Multilayered blood products
    Reapplix 2334307*

  • Treating or preventing gout
    Fonterra Corporate Research and Development; Fonterra 2334308*

  • TH1 vaccination priming for active immunotherapy
    Immunovative Therapies 2334309*

  • Adherent cells from placenta tissue and use thereof in therapy
    Pluristem 2334310*

  • Non-typeable haemophilus influenzae vaccines and their uses
    Hunter Immunology 2334311*

  • Compsns comprising plant extracts and use thereof for treating inflammation
    Nutriquine; Chamberland, Guy 2334312*

  • Process for the preparation of pramlintide
    ScinoPharm Taiwan 2334314*

  • Agents and methods for treatment of pain
    Abor Vita Corp; Nono 2334315*

  • Process for the synthesis of (AIB8,35)HGLP-1(7,36)-NH2
    Ipsen Manufacturing Ireland 2334316*

  • Stapled peptides and method of synthesis
    The Research Foundation of the State University of New York 2334317*

  • HIV-1 integrase derived stimulatory peptides interfering with integrase-rev protein binding
    Yissum Research Development Company of the Hebrew University of Jerusalem 2334318*

  • Method of reducing scarring during wound healing using antisense compounds directed to CTGF
    Excaliard Pharmaceuticals; Northwestern University 2334319*

  • Biopolymer conjugates comprising an interleukin-11 analogue
    Viromed; Biopolymed 2334320*

  • Analysis of HCV genotypes
    Vertex Pharmaceuticals 2334321*

  • GLP-1 fusion polypeptides
    Asterion 2334322*

  • Compsns and methods for the prevention of oxidative degradation of proteins
    F Hoffmann-La Roche 2334323*

  • BBeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury
    Fibrex Medical Research & Development 2334324*

  • Process for treatment of rheumatoid arthritis, tremors/Parkinson’s disease, multiple sclerosis and non-viral based cancers
    Salubrious Pharmaceuticals 2334325*

  • Mimotypes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
    Affris 2334326*

You may also like